Abstract
In the present study we investigated electrophysiologically the nicotinic responses of pyramidal neurons and interneurons visualized by infrared-assisted videomicroscopy and fluorescence in the CA1 field of hippocampal slices obtained from 8- to 24-day-old rats. Application of nicotinic agonists to CA1 neurons evoked at least four types of nicotinic responses. Of major interest was the ability of these agonists to induce the release of γ-aminobutyric acid (GABA) from interneurons. Slowly decaying ACh whole-cell currents and GABA-mediated postsynaptic currents could be recorded from pyramidal neurons and interneurons, whereas fast-decaying nicotinic currents and fast current transients were recorded only from interneurons. Nicotinic responses were sensitive to blockade by d-tubocurarine (10 μM), which indicated that they were mediated by nicotinic acetylcholine receptors (nAChRs). The slowly decaying currents, the postsynaptic currents and the fast current transients were insensitive to blockade by the α-7 nAChR-specific antagonist methyllycaconitine (up to 1 μM) or α-bungarotoxin (100 nM). On the other hand, the slowly decaying nicotinic currents recorded from the interneurons were blocked by the α4β2 nAChR-specific antagonist dihydro-β-erythroidine, and the fast-desensitizing nicotinic currents were evoked by the α-7 nAChR-specific agonist choline. In experimental conditions similar to those used to record nicotinic responses from neurons in slice (i.e., in the absence of tetrodotoxin), we observed that nicotinic agonists can also induce the release of GABA from hippocampal neurons in culture. In summary, these results provide direct evidence for more than one subtype of functional nAChR in CA1 neurons and suggest that activation of nAChRs present in GABAergic interneurons can evoke inhibitory activity in CA1 pyramidal neurons, thereby modulating processing of information in the hippocampus.
Although the psychological effects of the alkaloid nicotine have long been acknowledged (for a review see Stolerman et al., 1995), the physiological functions of neuronal nAChRs in the mammalian CNS remain unclear. For many years, the lack of specific agonists and antagonists for a given neuronal nAChR subtype severely limited the identification of functional nAChRs in various brain areas. This challenge was further aggravated by the fast kinetics of inactivation of some nAChR subtypes (reviewed in Sargent, 1993; Lindstrom, 1995; Albuquerque et al., 1995, 1997). With the development of systems that allow for agonists to be rapidly applied to and removed from the vicinity of neurons, and with the discovery of new pharmacological tools, it became possible to identify the various subtypes of functional nAChRs present on neurons from different brain areas, including the hippocampus (Alkondon and Albuquerque, 1993, 1994). Electrophysiological studies have shown that rapid exposure of ≈85% of cultured hippocampal neurons to nicotinic agonists results in activation of fast-decaying currents that are referred to as type IA currents. Type IA currents 1) are sensitive to blockade by α-BGT, MLA or α-CTX-ImI, 2) show an inward rectification that depends on the intracellular levels of Mg++, 3) display a rundown that can be prevented to a great extent by the presence of ATP-regenerating compounds in the intracellular solution and 4) are highly sensitive to modulation by extracellular levels of Ca++ (Alkondon et al., 1992, 1994; Alkondon and Albuquerque, 1993; Bonfante-Cabarcaset al., 1996; Pereira et al., 1996). Only 10% of the cultured hippocampal neurons respond to nicotinic agonists with slowly decaying currents that are sensitive to blockade by DHβE and are referred to as type II, and no more than 2% of the neurons respond to such agonists with slowly decaying currents that are sensitive to blockade by mecamylamine and are referred to as type III (Alkondon and Albuquerque, 1993; Alkondon et al., 1994).
The pharmacological and kinetic characteristics of type IA, type II and type III currents suggest that they are subserved by α-7 nAChRs, α4β2 nAChRs, and α3β4 nAChRs, respectively (Alkondon and Albuquerque, 1993; Alkondon et al., 1994). Potentially, activation of each of these receptors can lead to an increase of intracellular levels of Ca++ either indirectlyvia depolarization and consequent activation of voltage-gated Ca++ channels or directly because of Ca++ permeation through the nAChR channel. In this respect, α-7 nAChRs on hippocampal neurons, similar to α-7 nAChRs ectopically expressed on Xenopus oocytes, are highly permeable to Ca++ (Bertrand et al., 1993; Séguéla et al., 1993; Castro and Albuquerque, 1995).
Many of the biological functions identified to date for neuronal nAChRs have been associated with receptor-mediated changes in intracellular Ca++ and include modulation of release of different neurotransmitters (McGehee et al., 1995; Sacaanet al., 1995; Alkondon et al., 1996b; Grayet al., 1996; Sershen et al., 1997), modulation of neurite outgrowth (Pugh and Berg, 1994), control of synthesis and/or release of neurotrophins, regulation of early gene (e.g.,c-fos) transcript levels (Greenberg et al., 1986) and activation of second messengers (MacNicol and Schulman, 1992;Vijayaraghavan et al., 1995). In addition, mounting evidence suggests that CNS nAChRs are involved in controlling memory and learning. In fact, it seems that the brain cholinergic system (Aigner and Mishkin, 1986; Durkin, 1989; Dunnett and Fibiger, 1993) and the hippocampus (Squire, 1992; Bunsey and Eichenbaum, 1996) are vital components for memory processing in the mammalian CNS. Not only are nicotinic agonists able to improve cognition in experimental animals (see review by Stolerman et al., 1995), but also the number of neuronal nAChRs is markedly decreased in the cortex and hippocampus of patients with Alzheimer’s disease, a pathological condition characterized by progressive neurodegeneration and cognitive impairment (see review by Kellar and Wonnacott, 1990; Schröder et al., 1991; Maelicke and Albuquerque, 1996).
Numerous questions have been raised regarding the influence of neuronal nAChR activation on synaptic function in the hippocampus. Although initial studies have shown that, similar to neurons in the rat olfactory bulb and in the chick interpeduncular nucleus (McGeheeet al., 1995; Rocha et al., 1995; Alkondonet al., 1996b), neurons in the CA3 field of the rat hippocampus express an α-7 nAChR that modulates the release of glutamate from presynaptic terminals (Gray et al., 1996), the effects of nAChR activation on the synaptic activity in other areas of the hippocampus remain obscure. Thus, the main scope of the present study was to determine whether functional nAChRs are present on CA1 neurons, and if so, to investigate the effects of nicotinic agonists on the ongoing synaptic activity in the CA1 hippocampal field, a region that undergoes synaptic plasticity during learning (Huerta and Lisman, 1993; Bliss and Collingridge, 1993) and is also implicated in epileptogenesis (Lothman et al., 1993).
With the use of infrared-assisted videomicroscopy to visualize individual neurons in rat hippocampal slices and the patch-clamp technique, we have demonstrated that functional nAChRs are present on pyramidal neurons and interneurons of the CA1 field of the hippocampus and that activation of nAChRs present on CA1 interneurons induces the release of GABA.
Material and Methods
Preparation of hippocampal slices.
Sprague-Dawley rats (8 to 24 days old) were used in this study. The rats were deeply anesthetized in an atmosphere of CO2 with dry ice, and sacrificed by cervical dislocation. Their brains were removed and kept in ice-cold ACSF. The hippocampi were dissected out and cut into slices of 200- to 250-μm thickness either manually or with a vibratome. The cut slices were placed in a chamber containing ACSF at room temperature (20–22°C). The ACSF was continuously bubbled with 95% O2 and 5% CO2. After at least 1 h, a single slice was mounted in a round tissue chamber (1.5-ml capacity) and superfused continuously at a rate of 2 ml/min with oxygenated ACSF. ACSF had the following composition (in mM): NaCl, 125; NaHCO3, 25; KCl, 2.5; NaH2PO4, 1.25; CaCl2, 2; MgCl2, 1; and glucose, 25. Neurons present in the top layer within a depth of about 60 μm were successfully cleaned by applying a gentle stream of ACSF through a patch pipette with a tip diameter of about 10 μm. In about 30% of the experiments, the slices were exposed to the enzyme hyaluronidase (10 U/ml) for 30 to 45 min before starting the cleaning procedure. The nicotinic responses obtained in the neurons with and without the use of the enzyme did not differ to any noticeable extent. In many experiments cleaning of the neurons was achieved by a stream of internal solution coming out of the recording pipette to which positive pressure was applied.
Preparation of cultures of hippocampal neurons.
According to the procedure described in Alkondon and Albuquerque (1993), neurons dissociated from the hippocampus of Sprague-Dawley rat fetuses (16- to 18-day gestation) were plated onto poly-l-lysine-precoated coverslips placed in 35-mm plastic culture dishes (Nunc A/S, Kamstrupvej 90, Denmark). Neurons were used 18 to 21 days after plating.
IR-assisted videomicroscopy.
Neurons in culture and in slices were visualized through a Zeiss upright microscope (Zeiss Axioskop, New York, NY) using a 40× water-immersion objective (0.75 numerical aperture and 1.7 mm working distance) and DIC optics (Stuartet al., 1993; Alkondon et al., 1996a). After adjusting the specimen by the normal illumination light settings, an infrared filter (RG-9, λmax = 800 nm, Melles Griot, Rochester, NY) was brought into the light path, and the images were then detected with an infrared-sensitive videocamera (Newvicon C2400–07, Hamamatsu Photonics, Hamamatsu City, Japan) and displayed on a standard video monitor. Background subtraction and contrast enhancement of the images were done with an ARGUS 10 image processor (Hamamatsu City, Japan). The images were then either recorded on videotape or captured online by a Pentium computer with a frame grabber and ADOBE PREMIERE software (Version 1.0, Adobe Systems Inc., Mountain View, CA). Images of the neurons were printed on a Codonics NP-1600 photographic network printer (Codonics, Inc., Middleburg Heights, OH) after adjusting the contrast and brightness by the Micrographics program.
Fluorescence microscopy.
A fluorescence-sensitive camera was adapted to the Zeiss Axioskop so that it was possible to visualize the CA1 neurons in situ and to determine their morphology with a Lucifer yellow-containing solution in the patch pipettes. The neuronal morphology (pyramidal versus interneuron) could be identified by adding 0.4% Lucifer yellow to the internal pipette solution before making the whole-cell recordings. At the end of each experiment in which Lucifer yellow-containing internal solution was used, the image of the labeled neuron was captured by a color chilled 3CCD camera (Hamamatsu, Japan) and stored in the computer. The images of the neurons were then analyzed for branching pattern, which helped in confirming the morphology of the neurons under study and visualizing spine-rich regions along the dendritic surface.
Whole-cell current and voltage recording.
Whole-cell patch recording was performed at the cell soma of the neurons, and current or voltage changes induced by different agonists were recorded from hippocampal neurons according to the standard patch-clamp technique (Hamill et al., 1981) with an LM-EPC7 patch-clamp system (List Electronic, Darmstadt, FRG). The signals were filtered at 2 kHz and either recorded on video tape for later analysis or directly sampled by a microcomputer with the pCLAMP 6 program (Axon Instruments, Foster City, CA). The external bath solution for the slices was the same as the ACSF, but contained atropine (1 μM) to block the muscarinic receptors. The external bath solution for the culture experiment consisted of (in mM): NaCl, 165; KCl, 5; CaCl2, 2; glucose, 10; and HEPES, 5 (pH adjusted to 7.3 with NaOH; 330 mOsm). The internal solution used to fill the patch pipettes consisted of (in mM): EGTA, 10; HEPES, 10; and either CsCl, 160, KCl, 160, or the combination of CsCl, 80 and CsF, 80 (pH adjusted to 7.3 with CsOH or KOH, depending on the main cation in the solution; 330 mOsm). When the ATP-regenerating compounds phosphocreatine, creatine phosphokinase and ATP were included in the internal salt solution, the concentration of the main cation was decreased appropriately to adjust the osmolarity to 330 mOsm (Alkondonet al., 1994). Patch pipettes were made from a borosilicate glass capillary with a 1.2-mm outer diameter (World Precision Instruments, Sarasota, FL). When filled with the internal solution, the pipettes had resistances ranging from 2 to 6 MΩ. The access resistance during the whole-cell recordings was within 20 MΩ. All the recordings were performed at room temperature (20–22°C)
Agonist and antagonist application.
Agonists were applied to the neurons by one of the following protocols. Because of the limited working distance (1.7 mm between the specimen and the objective), a modified U-tube was fabricated in the laboratory by attaching a 1-cm cylindrical glass tube having an inner diameter of about 70 μm (outer diameter ≈ 150 μm) to the pore of a regular U-tube (Alkondon and Albuquerque, 1993), and glued at the joints to prevent any leakage. This extension of the U-tube permitted positioning of the tip within a distance of about 200 μm from the surface of the neurons. The modified U-tube had the same advantage as the regular U-tube such that several agonists could be applied to a single neuron. However, once the agonist was applied to the neurons through the modified U-tube, the solution could not be quickly removed by the same tube. In that case, the high flow rate (2 ml/min) and the small volume of the bath (1.5 ml) facilitated the removal of the agonists. In other experiments, a micromanifold system with a tip having 1-cm length and 100-μm inner diameter (ALA Scientific Instruments, Westbury, NY) was used. This system worked basically in the same way as the home-made U-tube. The small dead space of the micromanifold system facilitated rapid switching from one solution to another. However, agonists applied through this system to the neurons resulted in the activation of currents that had slower rise times than those evoked by application of agonists through the modified U-tube.
In the third method, agonists were applied focally to the cell soma by pressure ejection from a single micropipette (Alkondon et al., 1996a). In this method, a patch pipette (1.2 mm outer diameter) was filled with the agonist solution, and the tip (<0.7 μm inner diameter) was positioned close to the cell soma under study. Pulses of positive pressure (20 psi) of different duration were then applied to the pipette by a picoinjector (PLI-100, Medical Systems, Greenvale, NY). This technique had the advantage of activating a small population of receptors in a local area of the neuron. However, only one agonist could be tested at a time. Both the drug-delivery system and the whole-cell patch pipette were positioned and held in place by computer-operated nanorobot micromanipulators (Scientific Precision Instruments, Oppenheim, Germany). Antagonists were appliedvia the external bathing physiological solution. In some cases, antagonists were also included with the agonist in the U-tube system.
Data analysis.
The peak amplitude, rise time and decay time constants of the currents were analyzed with the pCLAMP program (Axon Instruments, Foster City, CA). The data are given either as mean ± S.E.M. or as individual values.
Drugs used.
ACh chloride, choline chloride, cytisine, (−)-nicotine hydrogen tartrate, 1,1-dimethylphenyl piperazinium iodide, GABA, picrotoxin, atropine sulfate, tetrodotoxin,d-TC, and hyaluronidase (type I-S) were obtained from Sigma Chemical Co. (St. Louis, MO). CNQX was obtained from Research Biochemical International (Natick, MA). α-BGT was purchased from Biotoxins, Inc. (St. Cloud, FL). (+)-Anatoxin-a fumarate was a gift from Prof. H. Rapoport (Department of Chemistry, University of California, Berkeley, CA). Methyllycaconitine citrate was a gift from Professor M.H. Benn (Department of Chemistry, University of Calgary, Alberta, Canada). (+)-Epibatidine hemioxalate was a gift from Dr. Ray Baker (Merck, Sharp & Dohme Research Laboratories, Harlow, Essex, UK). DHβE hydrobromide was a gift from Merck, Sharp & Dohme (Rahway, NJ). All chemicals were dissolved in double-distilled water, and the stock solutions (0.01–1 M) were kept frozen until ready to use. Stock solutions of CNQX (10 mM) were made in NaOH (12.5 mM), and those of picrotoxin (250 mM) were made in dimethyl sulfoxide.
Results
In this paper we present data on the properties of nicotinic acetylcholine responses recorded from CA1 neurons that underwent normal ontogenic development in vivo. These neurons were visually identified in hippocampal slices and morphologically characterized with the help of IR-DIC and fluorescence microscopy. The CA1 area of the hippocampus consists of a diverse group of neurons, including pyramidal neurons located in the stratum pyramidale and several types of interneurons present in the stratum oriens and alveus, stratum pyramidale, stratum radiatum and stratum lacunosum moleculare (see Morinet al., 1996). As described under “Material and Methods,” agonists were applied to neurons in the slicesvia a modified U-tube (Alkondon and Albuquerque, 1993), a micromanifold system (which served a similar purpose as the modified U-tube) or a single pipette (which was useful to restrict the neuronal surface covered by the agonist) (Alkondon et al., 1996a).
Images of neurons in the CA1 field of hippocampal slices
Based on the morphological features and on the location, the neurons studied in the CA1 region of hippocampal slices (area inside the rectangular box in fig. 1A) could be divided into two groups. The first group consisted of pyramidal neurons that were located in the stratum pyramidale. The second group consisted of interneurons that were located in the stratum pyramidale and in the stratum radiatum up to 300 μm from the midline of the pyramidal layer. Figure 1 illustrates sample images of individual neurons visualized in different layers of the CA1 field of hippocampal slices. The interneurons located in the stratum pyramidale and in the stratum radiatum had non-pyramidal-shaped soma and were devoid of prominent thick apical dendrites (fig. 1B). Most of the neurons in the stratum pyramidale had a pyramidal-shaped soma and prominent apical dendrites (fig. 1C). In addition, protrusions resembling spines were seen on some of the apical dendrites of pyramidal neurons and on the dendrites of interneurons (fig. 2). Fluorescence microscopy of Lucifer yellow-filled neurons not only confirmed the morphological features of pyramidal and non-pyramidal cells but also enabled identification of spiny dendritic regions (fig. 2).
Images of CA1 neurons in hippocampal slices. (A) Image of a 250-μm-thick slice which illustrates the different fields in the hippocampus. The slice was obtained from a 16-day-old rat. The CA1 and CA3 regions and the dentate gyrus (DG) are indicated by the arrows. Pyramidal neurons and interneurons were identified in the CA1 field (outlined by the rectangular box) by means of IR-DIC or by a combination of IR-DIC and fluorescence microscopy. (B and C) Infrared and fluorescence images of neurons visualized in the CA1 field of the hippocampus. (B, top frame) Infrared image of an interneuron located in the stratum pyramidale of a hippocampal slice obtained from a 17-day-old rat. The interneurons had a non-pyramidal-shaped cell body and thin dendrites, which could be easily seen in the fluorescence image obtained after the cell was filled with Lucifer yellowvia a whole-cell recording pipette (B, bottom frame). (C, left frame) Infrared image of a pyramidal neuron visualized in the CA1 field of a hippocampal slice obtained from a 15-day-old rat. Notice the typical characteristics of pyramidal-shaped cell body and thick, long and prominent apical dendrites, which can be easily visualized in the fluorescence image of the Lucifer yellow-filled pyramidal neuron (C, right frame).
Images of spine-rich dendrites.Upper frame shows the fluorescence images of two Lucifer yellow-filled interneurons in a single hippocampal slice from a 16-day-old rat. The neuron at the top was located 50 μm and the neuron at the bottom, 125 μm from the midline of the stratum pyramidale. The segment of secondary dendrite depicted between the two arrow heads in this frame is shown enlarged in the bottom frame. Arrows shown in the bottom frame indicate the presence of spines on this secondary dendrite. However, the images of most of the spines could not be captured in this two-dimensional picture.
Characteristics of nicotinic responses evoked in CA1 neurons
All experiments were carried out in the presence of atropine (1 μM) to block muscarinic receptors so that the responses evoked by nonspecific cholinergic agonists reflected exclusively the activation of nAChRs. Moreover, the use of TTX-free external solution kept the neuronal circuitry functional, so that it could be known whether action potentials and any subsequent action potential-dependent synaptic events could occur upon activation of nAChRs on CA1 hippocampal neurons.
Nicotinic responses of pyramidal neurons.
Application of physiological recording saline to pyramidal neurons caused neither change in the membrane current nor alterations in the frequency or amplitude of spontaneously occurring MPSCs (fig.3A). On the other hand, a 1-s pulse application of GABA (20 μM) to such neurons resulted in the activation of a slowly rising inward current that, after reaching the peak, declined to the baseline current level within about 5 s (fig. 3A). GABA-induced response was not accompanied by any change in the frequency of MPSCs.
Samples of nicotinic responses recorded from pyramidal neurons. Responses obtained from two neurons (labeled as A and B) are illustrated. Agonists were appliedvia the U-tube. The solid line shown above the first trace indicates the duration (1 s) of agonist pulses. The hippocampal slices were obtained from rats that were 15 days old (A) and 16 days old (B). The recording pipette was filled with a F−-containing, Cs+-based internal solution. A portion of the trace containing the PSCs is shown in an expanded scale in B. Holding potential, −50 mV.
In contrast to GABA, which elicited a single type of response, ACh and other nicotinic agonists elicited at least two types of responses when applied to pyramidal neurons. Out of the 26 pyramidal neurons studied, 17 responded to a 1-s pulse application of ACh (1 mM) with an inward current that had slow kinetics of activation and inactivation and was accompanied by several discrete PSCs (fig. 3A). The remaining nine neurons responded to 1-s pulse application of ACh (1 mM) exclusively with PSCs that could be observed for about 20 s after exposure to the nicotinic agonist (fig. 3B).
Nicotinic responses of interneurons.
Application of agonist-free physiological solution to interneurons changed neither the baseline noise nor the frequency of MPSCs (fig.4A). However, exposure of these neurons to GABA (20 μM)-containing external solution resulted in the elicitation of small inward currents (fig. 4A), and application of ACh to these neurons resulted in inward currents that had slow kinetics of activation and inactivation (fig. 4). The ACh-evoked currents had a prolonged decay phase, which lasted for several seconds even after termination of the agonist pulse (fig. 4B). Such slow nicotinic currents were recorded from 24 of 27 interneurons tested, and resembled the slowly decaying type II nicotinic currents that can be recorded from cultured hippocampal neurons (Alkondon and Albuquerque, 1993,1995). In 9 of 24 ACh-sensitive neurons, the slow nicotinic current was accompanied by bursts of current transients (see fig. 4A). These current transients, hereafter referred to as fast current transients, had the shape of inverted action potentials, and probably represented the active propagation of action potentials in the neurons under study. In 1 of 27 interneurons studied, ACh induced fast current transients without any noticeable slow nicotinic current. The frequency of the fast current transients elicited by ACh in the interneurons was variable from one neuron to another, and also in the same neuron, the frequency tended to decrease during the course of the experiment. In 2 of 27 interneurons tested, ACh induced an inward current that had both a rapidly and a slowly decaying component (see trace in fig. 4C); this current resembled type IB nicotinic currents recorded from cultured hippocampal neurons (Alkondon and Albuquerque, 1993). In all 27 interneurons tested, ACh also elicited PSCs (fig. 4); the frequency of ACh-evoked PSCs was variable among different neurons and was always less intense than that observed in pyramidal neurons.
Samples of nicotinic responses recorded from interneurons. Responses obtained from three neurons (labeled A, B and C) are illustrated. Agonists were applied for 2 s via a U-tube to neuron A, for 25 ms viaa single agonist pipette to neuron B and for 3 svia a micromanifold system to neuron C. Agonist pulses are indicated by solid lines above the traces in each section. Hippocampal slices were obtained from rats that were 16 days old (A), 12 days old (B) and 15 days old (C). All three interneurons were present in the stratum radiatum, and were located 200 μm (A), 250 μm (B) and 70 μm (C) from the midline of the stratum pyramidale. The recording pipette was filled with a F−-containing, Cs+-based internal solution. Holding potentials: −96 mV in A, −70 mV in B and −60 mV in C.
Characteristics of ACh-evoked PSCs.
PSCs evoked by ACh were compared with the spontaneously occurring MPSCs. In contrast to randomly and less frequently occurring MPSCs, the PSCs occurred at high frequencies during the agonist application. In the example illustrated in figure 5A, MPSCs occurred at 0.22 Hz, whereas ACh-elicited PSCs occurred at 1.11 Hz. Further, the amplitude distribution of MPSCs and ACh-evoked PSCs showed that the PSCs were substantially larger than the MPSCs (fig. 5A). The amplitude distribution of the MPSCs could be fitted to a single gaussian function with a mean value of 16.8 pA, whereas that of the agonist-evoked PSCs could be fitted by three gaussian functions with mean values of 17.2, 32.2 and 64.4 pA. Moreover, the MPSCs had a rise time (10–90%) of 2.07 ± 0.12 ms and a decay-time constant of 12.9 ± 0.4 ms, whereas the ACh-evoked PSCs had a rise time and a decay-time constant of 2.72 ± 0.13 ms and 19.9 ± 1.0 ms, respectively. These results suggested that both MPSCs and ACh-elicited PSCs are mediated by the same neurotransmitter, and that the PSCs are the result of the recruitment of more release sites during nAChR activation.
Analysis of MPSCs and ACh-elicited PSCs. (A) Plots show the distribution of the amplitudes and the cumulative distributions of the amplitudes of PSCs evoked by application of ACh to a single pyramidal neuron and of MPSCs. As illustrated, in the presence of ACh, a high frequency of large amplitude events could be seen. (B and C) Traces are representative samples of the PSCs recorded during application of ACh to two pyramidal neurons. ACh was applied to the neurons via the U-tube for 1 s (B) and for 2 s (C). Solid lines above the traces indicate the duration of agonist pulses. ACh-evoked PSCs could still be detected after a 12-min superfusion of the neuron with CNQX (right trace in B). However, after a 5-min superfusion of the neuron with picrotoxin, no PSCs could be detected during the application of ACh (right trace in C). Rats from which the slices were taken were 15 days old (A) and 8 days old (B). The recording pipette was filled with a F−-containing, Cs+-based internal solution. Holding potential, −50 mV.
To determine which neurotransmitter is being released by ACh and mediates the PSCs, we tested the sensitivity of ACh-evoked PSCs to blockade by CNQX, a competitive glutamate antagonist that inhibits fast glutamatergic transmission mediated by non- NMDA ionotropic receptors, and picrotoxin, a noncompetitive antagonist that blocks GABAergic transmission mediated by GABAA receptors. As shown in figure 5 (B and C), CNQX (10 μM) failed, whereas picrotoxin (100 μM) succeeded in blocking ACh-elicited PSCs, which indicates that these PSCs are indeed mediated by GABAAreceptors. These results indicate that nAChR activation is linked to the release of GABA, but not glutamate, in CA1 neurons.
Under the ionic conditions used in the present study and because of space-clamp problems, ion flux through GABAAreceptors in neurons held at values more negative than −19 mV can result in depolarization of unclamped areas of neurons. Such depolarization could conceivably lead to the activation of the fast current transients. However, ACh-evoked PSCs were not always accompanied by such fast current transients, and the appearance of the fast current transients did not correlate with the frequency of ACh-evoked PSCs, which thus suggests that the PSCs did not account for the generation of the fast current transients.
Responsiveness of CA1 neurons to receptor subtype-specific nicotinic agonists.
Nicotinic agonists are useful, to a certain extent, in discriminating the subtypes of nAChRs present on CNS neurons. To further authenticate the presence of functional nAChRs in the developing CA1 neurons and to get preliminary insights into the subunit composition of these receptors, we used various nicotinic agonists and studied the responses evoked by them.
In pyramidal neurons, the nicotinic agonists (+)-epibatidine, DMPP and AnTX were able to elicit responses (fig.6, A and B). At the concentrations used, these nicotinic agonists, unlike ACh, induced responses in which the PSCs were more prominent than the slow inward currents (see fig. 6), which suggests that the nAChR subtype subserving the slowly decaying currents is different from that mediating the agonist-evoked PSCs. Testing the ability of nAChR-subtype specific agonists to evoke nicotinic currents in pyramidal neurons provided further insights into the receptor subtype subserving the nicotinic responses under study. Choline, an α-7-specific nAChR agonist (Alkondon et al., 1997; Papke et al., 1996), acted as a very weak agonist when applied to pyramidal neurons that responded to ACh with slowly decaying currents accompanied by PSCs (fig. 6C). In other neurons (n = 3), choline (10 mM) induced exclusively PSCs. Contrariwise, cytisine and (−)-nicotine evoked slowly decaying currents and PSCs that had approximately the same magnitude as those evoked by ACh. Considering that cytisine is a very poor agonist at α4β2 nAChRs, it is unlikely that such receptors account for these nicotinic responses in pyramidal neurons.
Responses of pyramidal neurons to different nicotinic agonists. Responses obtained from three neurons (labeled as A, B and C) are illustrated. Agonists were applied to the neurons via the U-tube for 1 s (A and B) andvia the micromanifold system for 3 s (C). Solid lines above the traces indicate the duration of the agonist pulses. The rats from which slices were taken were 15 days old (A and B) and 19 days old (C). The recording pipette was filled with a F−-containing, Cs+-based internal solution. Holding potentials: −50 mV (A and B) and −60 mV (C).
Responses of interneurons to choline, cytisine and (−)-nicotine were also studied (fig. 7). The ability of the α-7 nAChR-specific agonist choline (10 mM) to evoke nicotinic responses was tested in 23 of the 27 interneurons sampled. In 13 of these 23 neurons, choline induced inward currents which decayed to the baseline values before termination of the agonist pulse (see first two traces in fig. 7A). These fast-decaying currents resembled α-7 nAChR-mediated type IA currents recorded from cultured hippocampal neurons (Alkondon and Albuquerque, 1993). In 7 of 13 such neurons, choline-induced fast-decaying currents were accompanied by PSCs (see second trace in fig. 7A). Of the remaining 10 interneurons, two did not respond to choline, six showed PSCs in response to choline (see first trace in fig. 7C) and two responded to choline with a slowly decaying inward current accompanied by fast current transients.
Responses of interneurons to different nicotinic agonists. Responses obtained from four interneurons (two in A, one in B and one in C) are illustrated. Agonists were applied to the neurons for the duration indicated by the solid lines on top of traces. The U-tube was used to apply the agonists to the first neuron in A, and the micromanifold system was used to apply the agonists to all other neurons. The rats from which slices were obtained were 16 days old (A), 15 days old (B) and 12 days old (C). All four interneurons were present in the stratum radiatum and were located between 125 and 200 μm from the midline of the stratum pyramidale. The recording pipette was filled with a F−-containing, Cs+-based internal solution. Holding potentials: −96 mV (top trace in A) and −60 mV (all the other traces). The traces in the right panel are the same recording as in the left panel but are shown on a compressed time scale.
The responses evoked by choline in interneurons were strikingly different from those induced by ACh. In neurons that responded to choline with fast-decaying currents, PSCs, or fast-decaying currents accompanied by PSCs, ACh always evoked a slowly decaying current (n = 18; see one example in fig. 7B). Thus, it is likely that at least two subtypes of nAChRs are present on a single interneuron, one of which may be composed of the α-7 subunit, as indicated by the ability of choline to evoke fast-decaying currents that resemble α-7 nAChR-mediated type IA currents.
In four of the interneurons sampled, both nicotine (n = 4) (see fig. 7C) and cytisine (n = 4) induced slowly decaying currents accompanied by PSCs; the slowly decaying currents evoked by either agonist had smaller amplitudes than those induced by ACh.
Responsiveness of CA1 neurons to receptor subtype-specific nicotinic antagonists.
The nonselective nicotinic antagonistd-TC (10 μM) blocked the ACh-evoked slow inward currents and PSCs in CA1 pyramidal neurons (n = 3 neurons) (fig.8). In addition, d-TC blocked ACh-evoked fast current transients recorded from interneurons (fig.9). The blocking effect ofd-TC was reversible within about 10 min after washing the neurons with d-TC-free physiological recording solution (figs. 8 and 9).
Effects of nicotinic blockers d-TC and MLA on ACh-induced responses recorded from pyramidal neurons. Responses obtained from two pyramidal neurons are shown. ACh was applied to the neurons for 1 svia the U-tube as indicated by the solid lines above the traces. (A) ACh-evoked currents were recorded under control conditions (left trace), 3 min after superfusion with 10 μM d-TC (middle trace) and 10 min after washing the neurons withd-TC-free external solution (right trace). (B) ACh-evoked currents were obtained under control conditions (left trace), 8 min after superfusion with 1 μM MLA (middle trace) and 12 min after washing the neurons with MLA-free external solution (right trace). The rat from which slices were obtained was 15 days old. The recording pipette was filled with a F−-containing, Cs+-based internal solution. Holding potential, −50 mV.
Pharmacological characterization of ACh-induced current transients in interneurons. Fast current transient induced by ACh in a single interneuron is shown. ACh was applied for 50 ms (as indicated by the solid line above the top traces) by pressure ejection from a single pipette. Traces in the first row represent ACh-evoked currents under control conditions (left trace) and 3 min after superfusion of the neuron with d-TC-containing external solution (right trace). The blocking effect of d-TC was reversed within 10 min of washing. Traces in the second row represent the current evoked by application of ACh to the same neuron before (left trace) and after 16-min superfusion with 100 nM α-BGT (right trace). Traces in the bottom row represent the current evoked by application of ACh to the same neuron before (left trace) and after 4 min superfusion with TTX-containing external solution (right trace). The rat from which hippocampal slice was obtained was 17 days old. The recording pipette was filled with a F−-free, Cs+-based solution containing ATP-regenerating compounds. Holding potential, −60 mV.
As illustrated in figure 8, the α-7 nAChR-selective antagonist MLA (up to 1 μM) did not affect the ACh-evoked inward current and PSCs recorded from pyramidal neurons. Also, α-BGT (100 nM) was unable to block ACh-evoked fast current transients recorded from the interneurons (fig. 9). The inability of MLA (1–100 nM) to block ACh-evoked inward currents and PSCs was also observed in five different pyramidal neurons (data not shown).
Our experiments also showed that the slowly decaying nicotinic currents recorded from interneurons were insensitive to blockade by α-BGT, but could be reversibly blocked by the α4β2 nAChR-specific antagonist DHβE (fig. 10).
Pharmacological characterization of ACh-induced slow currents in interneurons. Slow inward currents induced by application of ACh to a single interneuron are shown. ACh was applied to the neuron for 3 s (as indicated by the bar on the top of the first trace) via a micromanifold system. Traces, from top to bottom, represent the ACh-evoked current recorded in the absence of any blocker, 10 min after superfusion with α-BGT (100 nM), 3 min after superfusion with DHβE (10 μM) and 12 min after wash. The slice was obtained from a 15-day-old rat. This interneuron was located in the stratum radiatum 150 μm from the midline of the stratum pyramidale. Holding potential, −60 mV.
Mechanism underlying the release of GABA by nAChR activation
To delineate the mechanisms by which activation of nAChRs leads to induction of PSCs and fast current transients, we used the Na+-channel blocker, TTX. In the absence of TTX, ACh could induce either PSCs or slow inward currents accompanied by PSCs in pyramidal neurons, whereas in the presence of TTX, ACh-evoked PSCs could not be detected (see fig.11). Further, in interneurons that responded to ACh with fast current transients and few PSCs, TTX completely abolished both types of responses (see fig. 9). These results clearly indicate the involvement of Na+channels in inducing PSCs and fast current transients that occur on nAChR activation.
Effect of TTX on ACh-induced responses in pyramidal neurons. Responses obtained from two pyramidal neurons (labeled as A and B) are shown. ACh was applied for 1 svia the U-tube as indicated by the solid lines above the traces. Traces in the first row represent ACh-evoked responses recorded before (left trace) and after 2 min superfusion with TTX (right trace). Traces in the second row represent ACh-evoked responses before (left trace) and after 5 min superfusion with TTX (right trace). After recording the control responses, neurons were superfused with TTX-containing physiological solution and subsequently exposed to an admixture of ACh and TTX. The rats from which slices were obtained were 16 days old (A) and 10 days old (B). The recording pipette was filled with a F−-containing, Cs+-based internal solution. Holding potential, −50 mV.
Responses of cultured hippocampal neurons to nicotinic agonists in the absence of TTX
In our studies to date, nicotinic responses of hippocampal neurons in culture have always been recorded in the presence of TTX, thus precluding an investigation of the ability of nicotinic agonists to modulate release of neurotransmitters by acting on preterminal nAChRs. Thus, we investigated the responses evoked by application of nicotinic agonists to cultured hippocampal neurons in the absence of TTX. In TTX-free solutions, application of ACh to voltage-clamped hippocampal neurons in culture induced an inward current (indicated by asterisk in left column, trace 2 of fig. 12) that had the characteristics of type IA currents recorded in the presence of TTX (Alkondon and Albuquerque, 1993). However, this inward current, before decaying completely to the baseline level, was accompanied by a burst of GABA-mediated PSCs. The PSCs occurred as a consequence of nAChR activation because application of physiological saline to such neurons did not induce any membrane current changes or PSCs (left column, top trace in fig. 12). These responses resembled those recorded from some of the CA1 interneurons (see fig. 7A). In some cells, application of ACh evoked only PSCs; the direct nicotinic current component was either too small or could not be discerned clearly from the PSCs (data not shown). Choline (10 mM) induced responses identical to those evoked by ACh (see left column, trace 3 in fig. 12), which indicates that the nAChRs that mediate these events in the cultured neurons contain the α-7 subunits.
Pattern of nicotinic responses recorded from cultured hippocampal neurons in the absence of TTX. Left traces represent sample recordings of currents (first three traces) and voltage (last trace) changes induced by application of nicotinic agonists to a single hippocampal neuron cultured for 19 days. The agonists were applied for 2 svia a micromanifold system. Solid line above the top trace indicates the duration of the agonist pulse. Under the voltage-clamp condition, the neuron was held at −70 mV. The inward currents indicated by the asterisks represent the direct response that originates from activation of nAChRs on the neuron under study, whereas the PSCs that follow the initial current probably arise from GABAA receptors stimulated by GABA released by the activation of nAChRs present on neurons that synapse onto the neuron under study. Under the current-clamp mode, the fast voltage transient represents the action potential triggered by depolarization resulting from activation of nAChRs present on the neuron under study, and the subsequent events represent PSPs mediated by GABAAreceptors stimulated by GABA released because of activation of nAChRs present on neurons that synapse onto the neuron under study. The neuron had a resting membrane potential close to −60 mV. The recording pipette was filled with a KCl-containing internal solution. Right traces represent samples of currents (first two traces) and voltage (last trace) recorded from another hippocampal neuron cultured for 21 days. The agonist was applied for 25 ms by pressure ejection from a single pipette as shown by a solid line above the top trace. Under the voltage-clamp condition, the neuron was held at −70 mV. The first trace was sampled without application of agonist. Application of ACh induced a burst of fast current transients (second trace) and a burst of action potentials (third trace) in this neuron. The resting membrane potential was close to −70 mV. Recording pipette was filled with a KCl-based internal solution.
Application of either ACh (left bottom trace in fig. 12) or choline (data not shown) to such neurons under current-clamp condition evoked an initial voltage transient, which resembled an action potential and was followed by several PSPs. It is likely that the initial voltage transient was the result of an actively propagating action potential that was initiated because of the depolarization triggered by nAChR activation.
Pressure ejection of ACh onto other hippocampal neurons in culture initiated a burst of fast current transients without noticeable inward currents or PSCs (right column, middle trace in fig. 12). This response is similar to that elicited by ACh in some of the neurons in the hippocampal slices (see fig. 4). Applying ACh to such cultured neurons under the current-clamp condition resulted in the initiation of a burst of action potentials (right column, bottom trace in fig. 12). These observations supported the notion that fast current transients evoked by ACh in the neurons of hippocampal slices are caused by the active propagation of action potentials that were initiated by the depolarization subsequent to nAChR activation.
The subtype of nAChR that is responsible for the initiation of action potentials in the cultured hippocampal neurons was characterized pharmacologically. In the presence of the GABAAreceptor antagonist picrotoxin, random firing of spontaneous action potentials was recorded from some hippocampal neurons in culture. Application of ACh, choline or (−)-nicotine to these neurons resulted in the generation of bursts of action potentials that was insensitive to blockade by DHβE. When the same agonists were applied to the neurons after bath-application of MLA (1 nM) for 6 to 8 min, they did not elicit the typical burst of action potentials seen under control conditions (fig. 13). Washing the neurons resulted in the restoration of the effects of the nicotinic agonists (fig. 13). These results support the concept that activation of an nAChR that contains the α-7 subunit is responsible for the initiation of action potentials in the cultured hippocampal neurons.
Pharmacological characterization of the nicotinic agonist-mediated action potentials in cultured neurons.Voltage responses of a single hippocampal neuron to the application of different nicotinic agonists. The agonists were applied for 2 svia a micromanifold system. Solid lines shown at the bottom of each column of traces indicate the duration of agonist pulses. The resting membrane potential was close to −70 mV. The neuron was cultured for 19 days. The first row of traces represent sample recordings obtained during the application of physiological saline, which did not change the firing pattern of the neuron. Application of ACh, choline or (−)-nicotine induced bursts of action potentials (rows 2–4, column 1). After superfusion of the neuron for 6 to 8 min with MLA, these agonists did not elicit the burst of action potentials (rows 2–4, column 2). After washing the neuron with MLA-free physiological solution for 10 to 12 min, the responses of the neuron to the agonists were similar to those recorded under the control condition (rows 2–4, column 3).
Discussion
In the present study, we demonstrate that functional nAChRs are present in visually identified pyramidal neurons and interneurons of the CA1 field of the hippocampus of developing rats. Application of nicotinic agonists to CA1 neurons evoked action potentials as well as whole-cell currents that were either fast decaying (in interneurons) or slowly decaying (in pyramidal neurons and interneurons). Of major interest, however, was the finding that the predominant response of CA1 neurons to nicotinic agonists is the release of GABA, evidenced by the ability of nicotinic agonists to induce GABA-mediated PSCs in pyramidal neurons and interneurons.
Characterization of the nicotinic responses recorded from CA1 neurons in hippocampal slices.
Similarly to hippocampal neurons in culture, neurons in the CA1 field of hippocampal slices showed pharmacologically and kinetically distinct responses upon rapid application of nicotinic agonists. To compare the kinetics of the nicotinic responses recorded from hippocampal neurons in slices with that of the nicotinic currents recorded from hippocampal neurons in culture, it was necessary to take into account that the diffusion barriers in the slices slow down the agonist access to the neurons and that the agonist-delivery systems used to investigate the nicotinic responses of neurons in the slices were much slower than those used to obtain the responses of the neurons in culture. These factors contribute to slower kinetics of receptor activation and inactivation. Thus, the fastest nicotinic response of CA1 neurons in the slice (see fig. 7A) would correspond to the type IA currents recorded from the cultured neurons, and the slower decaying current recorded from the neurons in the slice (see figs. 7 and 11) would be equivalent to the type II currents recorded from hippocampal neurons in culture. The fast-decaying current, which was recorded predominantly from interneurons of the CA1 field of the hippocampal slices, was unveiled only when the α-7 nAChR-specific agonist choline was used, which suggests that such response is most likely subserved by an α-7 nAChR. Most of the neurons that showed a fast-decaying current in response to choline responded to nonspecific nicotinic agonists with a whole-cell current that had a fast- and a slow-decay component, or with a current that decayed very slowly. This finding could be explained by the ability of such nonspecific agonists to activate both rapidly and slowly desensitizing nAChRs, and by the fact that, depending on its magnitude, a slowly decaying current can easily mask a rapidly decaying current. Moreover, this finding indicates that a single neuron can express more than one subtype of functional nAChR.
The slowly decaying current recorded from interneurons most likely is subserved by an α4β2 nAChR because of the sensitivity of these currents to blockade by DHβE; and the slowly decaying currents recorded from the pyramidal neurons most likely are subserved by a different nAChR subtype, because cytisine, a poor α4β2 nAChR agonist (Alkondon and Albuquerque, 1995), was as effective as ACh as an agonist in evoking the slowly decaying currents in pyramidal neurons.
In addition to the nicotinic agonist-evoked whole-cell currents, a high frequency of PSCs was consistently evoked by application of nicotinic agonists to pyramidal neurons and could be recorded even from neurons that did not exhibit a “direct” nicotinic current. It should be mentioned that in interneurons PSCs were fewer in number during nAChR activation. Many nicotinic agonists such as (+)AnTX, choline and (−)-nicotine, at the concentrations used, were able to elicit PSCs without evoking substantial direct nicotinic currents in CA1 pyramidal neurons and in some interneurons, which suggests that the two events may be mediated by different subtypes of nAChRs.
The PSCs evoked by nicotinic agonists were blocked by picrotoxin, but not by CNQX, which indicates that these currents were mediated by GABA released from presynaptic GABAergic neurons upon nAChR activation. The finding that TTX prevented nicotinic agonist-induced GABA release from CA1 neurons supported our earlier suggestion that nAChRs controlling release of GABA may be located on the axons of GABAergic CA1 neurons (Albuquerque et al., 1997). Such “preterminal” nAChRs have also been found in neurons of rat interpeduncular nucleus (Léna et al., 1993) and avian lateral spiriform nucleus (McMahon et al., 1994). Although activation of muscarinic receptors on CA1 neurons has been shown to increase the release of GABA (Pitler and Alger, 1992), muscarinic receptors did not account for any of our results, because 1) the muscarinic receptor antagonist atropine (1 μM) was present in all solutions, and 2) compounds that are known to activate nicotinic but not muscarinic receptors (e.g., AnTX, (−)-nicotine, cytisine and (+)-epibatidine) were also capable of evoking responses that resembled those evoked by ACh in the presence of atropine.
Bursts of fast current transients, appearing like bursts of action potentials, were also induced by application of nicotinic agonists to interneurons, which suggests that nAChR-mediated fast current transients are characteristic nicotinic responses of nonpyramidal neurons.
The sensitivity of the nicotinic responses recorded from neurons in the CA1 field of hippocampal slices to blockade by d-TC supported the notion that these responses were mediated by an nAChR, but could not provide definitive clues regarding the nature of the nAChR subtype involved because of lack of selectivity ofd-TC to any particular nAChR subtype. Considering that in CA1 hippocampal neurons, the levels of mRNA coding for the α-7 subunit are very high (Séguéla et al., 1993) and that α-7 nAChR-mediated currents are the prevalent responses of cultured hippocampal neurons to nicotinic agonists (Alkondon and Albuquerque, 1993), we analyzed the sensitivity of the nicotinic responses recorded from CA1 neurons to MLA and α-BGT, which specifically inhibit the activation of α-7 nAChRs (Alkondon et al., 1992, 1994; Gray et al., 1996; Albuquerqueet al., 1997).
MLA up to 1 μM, a concentration 1000-fold higher than that required to completely block α-7 nAChR-mediated type IA currents in cultured hippocampal neurons, did not block the slowly decaying nicotinic currents recorded from pyramidal neurons. Likewise, α-BGT did not affect nicotinic agonist-induced fast current transients in interneurons. The insensitivity to MLA or α-BGT suggests a priori that these nicotinic responses may not be subserved by α-7 nAChRs. Taking into account the high levels of mRNA coding for α-7 subunit and the high levels of α-BGT binding sites (which are likely to represent the levels of α-7 subunits) in hippocampal neurons (Pauly et al., 1989; Séguéla et al., 1993), it is possible that the slowly decaying currents and the fast current transients recorded from the CA1 neurons were evoked by the activation of nAChRs made up of a combination of α-7 and other subunits. In fact, it has been reported that nAChRs containing α-7 and other subunits have kinetics and sensitivities to α-BGT and MLA that are different from those of the homomeric α-7 nAChRs (Yumet al., 1996).
As mentioned previously, however, the fast-decaying currents recorded from CA1 interneurons are likely to be mediated by an α-7 nAChR, because these responses could be evoked by the α-7 nAChR-specific agonist choline and resembled kinetically the α-7 nAChR-mediated type IA currents recorded from cultured hippocampal neurons. Considering the discrepancy between the proportion of cultured hippocampal neurons exhibiting α-7 nAChR-mediated nicotinic responses and the proportion of CA1 neurons showing responses that are presumably mediated by an α-7 nAChR, it is feasible that our culture conditions might favor the survival of the hippocampal neurons that express α-7 nAChRs. Alternatively, it is also possible that the lack of the major cholinergic input to the hippocampal neurons in culture favors the expression of α-7 nAChRs in these neurons. In fact, it has been shown that the cholinergic innervation to the muscle endplate plays a key role in the developmental changes of the muscle nAChRs in vivo (Betz and Osborne, 1977; Schuetze and Vicini, 1984; Kueset al., 1995).
TTX-sensitive nicotinic responses recorded from hippocampal neurons in culture and from neurons in the CA1 field of hippocampal slices.
In voltage-clamped cultured hippocampal neurons, ACh evoked fast current transients similar to those recorded from CA1 interneurons exposed to nicotinic agonists. When the same cultured hippocampal neurons were current clamped, ACh evoked action potentials. These action potentials could also be induced by the α-7-selective agonist choline, and were sensitive to blockade by the α-7-selective antagonist MLA, which indicates that in cultured hippocampal neurons, activation of α-7 nAChRs can result in depolarization sufficient to trigger action potentials.
Irrespective of the nAChR subtype present on hippocampal neurons in slices and in cultures, it is likely that the action potentials triggered by activation of these receptors on the soma or dendrites of the neurons (Alkondon et al., 1996a) are generated in a fashion similar to those triggered by the injection of current in the distinct areas of the neurons (Stuart and Sakmann, 1994). In some experiments, fast current transients or action potentials were not accompanied by large nicotinic currents or depolarization, which suggests that even a small depolarization, which may not have been detected in our experiments, is sufficient to initiate action potentials.
The action potentials initiated by nAChR activation could affect the neuronal function in two ways. First, the action potential might invade the dendrites of the same neuron by back-propagation, causing Ca++ influx in the dendrites and affecting the synaptic efficacy. This has taken place in neocortical neurons and in CA1 pyramidal neurons (Markram et al., 1997; Sprustonet al., 1995). Second, the action potentials might invade the axon terminals and trigger the release of neurotransmitters onto neighboring neurons. The elicitation of PSCs by nAChR activation, and their blockade by TTX, is strong evidence that activation of nAChRs present on CA1 GABAergic neurons can initiate action potentials that, by invading the axon terminal, lead to the release of GABA.
The involvement of nAChRs in a local neuronal circuitry in the CA1 field of the hippocampus.
Our findings provide direct evidence that functional nAChRs are present on the surface of both CA1 pyramidal (P, fig. 14) and interneurons (I, fig.14) and that the receptors present in the interneurons modulate GABA release.
Proposed scheme of nicotinic actions on CA1 hippocampal neurons. Three pathways (A–C) are proposed to explain the nicotinic responses recorded from neurons in the CA1 field of the rat hippocampus. In A, the neuron under study receives an autaptic input from its own axon, and a GABAergic input from another neuron. In B, the neuron under study receives a GABAergic input from another neuron. In C, the neuron under study gives out a glutamatergic output to a GABAergic neuron, which in turn provides an inhibitory connection to the primary neuron. P, pyramidal neurons; I, interneurons; a, axon. Open triangles represent GABAergic and filled triangle represents glutamatergic boutons. Arrows indicate the main axonal pathway for the neuron under study. The tip of a patch pipette is shown on each neuron under study.
Different pathways could have been involved in the nAChR-induced, GABA-mediated PSCs depending on the neuronal type studied (pyramidalversus interneuron) in the hippocampal slice. For instance, when an interneuron was being studied (A, fig. 14), there could have been at least two sources for the nAChR-induced PSCs. First, the PSCs could have been the result of GABA release induced by the depolarization triggered by activation of nAChRs on another interneuron which synapses onto the neuron under study. Second, the interneuron under study could have made an autaptic synapse with its own cell body or dendrites. This being the case, because of the space-clamp problems that arise from the needle clamp in the whole-cell patch, nAChR-mediated depolarization of unclamped areas of the axon could initiate action potentials that invade the autaptic terminals and induce the PSCs. Such autaptic connections are very common in cultured hippocampal neurons (Bekkers and Stevens, 1991; Segal, 1991), and may very well explain the PSCs induced by nAChR activation in these neurons. However, the extent to which autaptic connections exist in the interneurons of the developing hippocampus is unknown. A recent study carried out on layer V pyramidal neurons of the developing rat neocortex indicated that about one third of their synaptic contacts could come from autapses (Lübke et al., 1996).
In pyramidal neurons, PSCs elicited by nAChR activation could arise from two mechanisms as illustrated in schemes B and C of figure 14. Similar to the mechanism mentioned above, the activation of nAChRs present on various interneurons could result in the release of GABA at the synapses made onto the pyramidal neurons. Then, GABA, in turn, by activating GABAA receptors on the pyramidal neurons leads to the activation of PSCs. Alternatively, action potentials generated in the axon of pyramidal neurons by nAChR activation could release glutamate onto an interneuron viaan axon collateral. Glutamate, then, could lead to the increased excitability of the interneuron, which, in turn, would release GABA at its synapses onto the pyramidal neuron under study, resulting in the PSCs. We favor scheme B over C, because, in our experiments, nicotinic agonists were not seen to evoke fast current transients, reminiscent of action potentials, in pyramidal neurons in slices. Further, the inability of CNQX, a glutamate receptor antagonist, to block the PSCs makes scheme C unlikely.
Physiological significance of nAChR-mediated modulation of GABA release in the hippocampus.
After exposure to nicotinic agonists, the frequency of GABA-mediated PSCs was always much higher in recordings obtained from pyramidal neurons than in those obtained from interneurons, which thus indicates that nicotinic agonists may have a profound inhibitory influence on the activity of CA1 pyramidal neurons. According to our findings, if a neuronal network composed of interneuron ⇒ interneuron ⇒ pyramidal neuron exists, nAChR activation in the second interneuron should be very effective in increasing the inhibitory tonus to the pyramidal neuron, thereby overriding a possible functional disinhibition of the pyramidal neuron (Tóth et al., 1997). This disinhibition could occur in such a neuronal network only if nicotinic agonist-induced GABA release from the first interneuron in the circuitry were sufficient to silence the interneuron that synapses onto the pyramidal neuron. Thus, the frequency and timing of cholinergic stimuli arriving at the various CA1 interneurons may be essential in determining the magnitude of the output signals of the CA1 pyramidal neurons.
In the hippocampus, pyramidal neurons outnumber interneurons such that each interneuron, by virtue of its extensive axonal arborization, is capable of inhibiting many pyramidal neurons. Further, each CA1 pyramidal neuron can be innervated by as many as 25 basket cells, and each basket cell can form up to 12 synaptic contacts on the soma and proximal dendrites of the pyramidal neurons (Buhl et al., 1994), which thus ensures an effective inhibition of the activity of these neurons. Moreover, axoaxonic cells, by innervating predominantly the initial axon segments, and bistratified cells, by innervating predominantly the dendrites of pyramidal cells, constitute additional inhibitory pathways within the hippocampal circuitry (Buhl et al., 1994). GABAergic interneurons have been effective in synchronizing pyramidal cell activity (Cobb et al., 1995). This was attributed to the θ oscillatory activity induced by the perisomatic GABAA-receptor-mediated synaptic events (Fox, 1989; Soltesz and Deschênes, 1993). θ-Frequency oscillations can also be brought about in the hippocampus by the cholinergic neurons (Bland, 1986), and such oscillations induced by cholinergic agonists have been shown to enhance the synaptic efficacy in the CA1 neurons (Huerta and Lisman, 1993). The θ rhythm is frequently recorded from the hippocampus of animals subjected to learning tasks (Winson, 1978; Otto et al., 1991), which suggests that nAChR-mediated modulation of GABA release onto CA1 pyramidal neurons may be a mechanism underlying the ability of nicotinic agonists to improve learning and memory.
The finding that activation of a neuronal nAChR on CA1 hippocampal neurons modulates the release of GABA may also provide the basis for the understanding of the mechanism by which an intact forebrain cholinergic innervation is essential to suppress kindling epileptogenesis in the hippocampus (Kokaia et al., 1996). Recent studies in rats have shown that selective immunolesioning of basal forebrain cholinergic neurons with the immunotoxin 192IgG-saporin results in a marked facilitation of the initial stages of seizure development in hippocampal kindling (Kokaia et al., 1996), which appears to be directly associated with a reduction of GABAergic inhibition in the CA1 field of the hippocampus (Lothman et al., 1993). Because activation of muscarinic receptors (Pitler and Alger, 1992) and nAChRs increases the release of GABA from CA1 interneurons, it is conceivable that facilitation of the development of seizures caused by the destruction of the major cholinergic input to the hippocampus is a result of the reduced activation of both muscarinic and nicotinic receptors in this brain area. In addition, our finding that the nAChR controlling GABA release from CA1 hippocampal neurons is insensitive to MLA sheds new light on the mechanism underlying the ability of nicotine to induce seizures in experimental animals, given that this effect of nicotine, which is believed to initiate in the hippocampus (Brown, 1967; Stumpf and Gogolak, 1967), cannot be prevented by MLA (Gasior et al., 1996). It is possible that nicotine-induced desensitization of the MLA-insensitive nAChRs present on CA1 hippocampal neurons accounts for its ability to induce seizures in the experimental animals.
A recent study has also implicated α-7 nAChRs in schizophrenia by providing linkage data supporting the involvement of the α-7-nAChR gene in the pathophysiological aspect of the illness (Freedman et al., 1997). The authors of that study attributed the attentional deficit seen in patients with schizophrenia to a decrease in the inhibitory control to the hippocampal pyramidal neurons. Our present results provide direct evidence for the existence of a mechanism by which nAChRs may control the inhibitory tonus in the hippocampus.
In conclusion, this study demonstrates that diverse subtypes of functional nAChRs (such as α-7-containing nAChRs, α4β2-containing nAChR and possibly nAChRs containing other subunits) are expressed in the pyramidal neurons and interneurons of the CA1 field of the rat hippocampus, and that activation of nAChRs present on the interneurons can control the excitability of pyramidal neurons and possibly of other interneurons by modulating the release of GABA.
Acknowledgments
The authors thank Mabel Zelle, Barbara J. Marrow and Benjamin Cummings for their excellent technical assistance.
Footnotes
-
Send reprint requests to: Dr. Edson X. Albuquerque, Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, 655 West Baltimore Street, Baltimore, MD 21201.
-
↵1 This study was supported by US Public Health Service Grant NS25296 and Programa de Apoio a Núcleos de Excelência (PRONEX, Brazil).
- Abbreviations:
- nAChR
- nicotinic acetylcholine receptor
- CNS
- central nervous system
- α-BGT
- α-bungarotoxin
- MLA
- methyllycaconitine
- α-CTX-ImI
- α-conotoxin-ImI
- DHβE
- dihydro-β-erythroidine
- LTP
- long-term potentiation
- PSC
- postsynaptic current
- GABA
- γ-aminobutyric acid
- ACSF
- artificial cerebrospinal fluid
- DIC
- differential interference contrast
- HEPES
- N-[2-hydroxyethyl]piperazine-N′-[2-ethanesulfonic acid]
- EGTA
- ethyleneglycoltetraacetic acid
- TTX
- tetrodotoxin
- MPSCs
- miniature postsynaptic currents
- CNQX
- 6-cyano-7-nitroquinoxaline-2,3-dione
- NMDA
- N-methyl-d-aspartate
- ACh
- acetylcholine
- DMPP
- dimethyl phenyl piperazinium
- AnTX
- (+)-anatoxin-a
- d-TC
- d-tubocurarine
- PSP
- postsynaptic potential
- IR
- infrared
- DIC.
- Received July 28, 1997.
- Accepted October 21, 1997.
- The American Society for Pharmacology and Experimental Therapeutics